Mode
Text Size
Log in / Sign up
N/A N=250

Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement

Postoperative Delirium · Aortic Valve Stenosis

Enrolled (actual)
250
Serious AEs
29.6%
Results posted
Feb 2023
Primary outcome: Primary: Number of Participants With Postoperative Delirium — 13; 41; 45 Participants — p=<0.0001

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Older Adult · 70+ yrs
Sex
All
Sponsor
Universitaire Ziekenhuizen KU Leuven
Primary completion
Jan 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Postoperative Delirium
13; 41; 45 <0.0001 sig
SECONDARY
Onset Moment of Postoperative Delirium
4; 3; 4
SECONDARY
Duration of POD
4; 3; 4
SECONDARY
Severity of POD
6; 5; 5
SECONDARY
Number of Patients With Adverse Events According to the Composite Endpoint Early Safety According to VARC-2 at 30 Days
31; 22; 20
SECONDARY
Number of Patients With Adverse Events According to the Composite Endpoint Clinical Efficacy According to VARC-2 at 6 Months
32; 21; 18
SECONDARY
Assessment of Instrumental Activities of Daily Living During 6-months Interview
8.3; 10.8; 11.1
SECONDARY
Intensive Care Unit (ICU) Length of Stay
29; 47; 46
SECONDARY
Hospital Length of Stay
4; 8; 10
SECONDARY
Count of Patients Discharged Directly Home
71; 47; 55

Summary

Our primary aim in this observational study is to identify the incidence of POD in the first five postoperative days by using the 3-minute Diagnostic confusion assessment method (3D-CAM), the derived version for intensive care unit (CAM-ICU) or nurse reports in patients undergoing different techniques of aortic valve replacement. Patients are followed 5 days postoperative with the 3D-CAM or until resolution of POD. Six months postoperatively, a follow-up by phone is planned for activity of daily living (ADL).

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to undergo elective
  • TAVI
  • SAVR (with or without coronary artery bypass grafting (CABG) or pulmonary vein isolation (PVI))
  • Patient able to read and understand the research materials

Exclusion Criteria

  • Inability to give informed consent
  • Presence of delirium at baseline as screened with the 3-minute Diagnostic Confusion Assessment Method (3D-CAM)
  • Combined surgical procedures (e.g. mitral valve surgery, aortic surgery or other)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03950440). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search